Phenotypic synergy testing of ceftazidime–avibactam with aztreonam in a university hospital having high number of metallobetalactamase producing bacteria
暂无分享,去创建一个
M. Gurjar | C. Sahu | Sanjay Singh | U. Ghoshal | Souravi Pal | S. Patel
[1] R. Shrivastava,et al. High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam. , 2020, The Journal of antimicrobial chemotherapy.
[2] B. George,et al. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study , 2019, Indian journal of medical microbiology.
[3] J. Chow,et al. Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme , 2018, The Journal of antimicrobial chemotherapy.
[4] M. Shirley. Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections , 2018, Drugs.
[5] M. Kollef,et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. , 2017, The Lancet. Infectious diseases.
[6] B. Veeraraghavan,et al. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies , 2017, Indian journal of medical microbiology.
[7] M. Castanheira,et al. 1686. Antimicrobial Activity of Aztreonam-avibactam, Ceftazidime-Avibactam, and Comparator Agents against Pseudomonas aeruginosa from Cystic Fibrosis Patients , 2017, Open Forum Infectious Diseases.
[8] E. Wenzler,et al. Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens. , 2017, Diagnostic microbiology and infectious disease.
[9] S. Mohanty,et al. Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: A molecular study from India , 2017, Indian journal of medical microbiology.
[10] M. Rottman,et al. Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa , 2017, Antimicrobial Agents and Chemotherapy.
[11] E. Larson,et al. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? , 2017, GMS hygiene and infection control.
[12] R. Humphries,et al. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? , 2017, Antimicrobial Agents and Chemotherapy.
[13] J. Rolain,et al. Plasmid-Mediated mcr-1 Gene in Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae in France and Laos , 2016, Antimicrobial Agents and Chemotherapy.
[14] Y. Carmeli,et al. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. , 2016, The Lancet. Infectious diseases.
[15] N. Indrawattana,et al. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens , 2016, BioMed research international.
[16] L. Hoang,et al. Rapid Detection of KPC, NDM, and OXA-48-Like Carbapenemases by Real-Time PCR from Rectal Swab Surveillance Samples , 2015, Journal of Clinical Microbiology.
[17] D. Nair,et al. Extended-spectrum β-lactamases in Gram Negative Bacteria , 2010, Journal of global infectious diseases.
[18] T. Bannerman,et al. Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[19] D. Mathai,et al. Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa. , 2010, Indian journal of medical microbiology.
[20] N. Masuda,et al. Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.
[21] J. Verweij,et al. Extended-spectrum β-lactamase (ESBL) polymerase chain reaction assay on rectal swabs and enrichment broth for detection of ESBL carriage. , 2018, The Journal of hospital infection.